| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Creotech Instruments S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł43.10 |
| 52 Week High | zł50.20 |
| 52 Week Low | zł35.10 |
| Beta | -0.036 |
| 1 Month Change | -11.13% |
| 3 Month Change | 13.42% |
| 1 Year Change | 11.08% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 85.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5OB | DE Aerospace & Defense | DE Market | |
|---|---|---|---|
| 7D | -11.1% | -0.9% | -0.3% |
| 1Y | 11.1% | 44.4% | 4.5% |
Return vs Industry: 5OB underperformed the German Aerospace & Defense industry which returned 44.4% over the past year.
Return vs Market: 5OB exceeded the German Market which returned 4.5% over the past year.
Price Volatility
| 5OB volatility | |
|---|---|
| 5OB Average Weekly Movement | n/a |
| Aerospace & Defense Industry Average Movement | 4.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 5OB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 5OB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 180 | Grzegorz Brona | www.creotech.pl |
Creotech Instruments S.A. operates in the space and science industry in Poland. The company produces aircrafts, spacecrafts, electronic components, computers and peripheral devices, telecommunications equipment, and related machines. It also manufactures measuring, control, and navigation instruments and devices; produces and distributes electricity; and produces control apparatus.
Creotech Instruments S.A. Fundamentals Summary
| 5OB fundamental statistics | |
|---|---|
| Market cap | €111.36m |
| Earnings (TTM) | -€2.71m |
| Revenue (TTM) | €7.28m |
15.3x
P/S Ratio-41.2x
P/E RatioIs 5OB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5OB income statement (TTM) | |
|---|---|
| Revenue | zł30.95m |
| Cost of Revenue | zł12.48m |
| Gross Profit | zł18.47m |
| Other Expenses | zł29.98m |
| Earnings | -zł11.50m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 29, 2024
| Earnings per share (EPS) | -4.83 |
| Gross Margin | 59.69% |
| Net Profit Margin | -37.17% |
| Debt/Equity Ratio | 8.0% |
How did 5OB perform over the long term?
See historical performance and comparison